Federal Register / Vol. 75, No. 15 / Monday, January 25, 2010 / Notices 3911 

Dated: January 11, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–1158 Filed 1–22–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), and pursuant to the 

requirements of 42 CFR 83.15(a), the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the 

aforementioned committee: 

Board Public Meeting Times and Dates 

(All Times Are Pacific Standard Time) 

8:45 a.m.–4:30 p.m., February 9, 2010. 

9 a.m.–6 p.m., February 10, 2010. 

9 a.m.–3 p.m., February 11, 2010. 

Public Comment Times and Dates (All 

Times Are Pacific Standard Time) 

4:30 p.m.–6 p.m., February 9, 2010.* 

6 p.m.–7:30 p.m., February 10, 2010.* 

*Please note that the public comment 

periods may end before the times 

indicated, following the last call for 

comments. Members of the public who 

wish to provide public comment should 

plan to attend public comment sessions 

at the start times listed. 

Place: Marriott Manhattan Beach, 

1400 Parkview Avenue, Manhattan 

Beach, California; Phone: (310) 546– 

7511; Fax: (310) 939–1486. Audio 

Conference Call via FTS Conferencing. 

The USA toll free dial-in number is 1– 

866–659–0537 with a pass code of 

9933701. 

Status: Open to the public, limited 

only by the space available. The meeting 

space accommodates approximately 100 

people. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program (EEOICP) Act of 2000 to advise 

the President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the Advisory 

Board to HHS, which subsequently 

delegated this authority to the CDC. 

NIOSH implements this responsibility 

for CDC. The charter was issued on 

August 3, 2001, renewed at appropriate 

intervals, and will expire on August 3, 

2011. 

Purpose: This Advisory Board is 

charged with (a) Providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

Matters To Be Discussed: The agenda 

for the Advisory Board meeting 

includes: NIOSH Program Update and 

Program Evaluation Plans; Department 

of Labor (DOL) Program Update; 

Department of Energy (DOE) Program 

Update; OCAS Science Update; Special 

Exposure Cohort (SEC) petitions for: 

Lawrence Livermore National 

Laboratory, Santa Susana Area IV, 

Canoga Avenue Facility (Los Angeles 

County, California), Lawrence Berkeley 

National Laboratory, General Electric 

Company (Evendale, Ohio), Blockson 

Chemical Company, Chapman Valve 

Manufacturing Company, United 

Nuclear Corporation (Hematite, 

Missouri), Hanger 481 at Kirtland Air 

Force Base, Nevada Test Site, and 

Westinghouse Electric Corportation 

(Bloomfield, New Jersey); SEC Petition 

Status Updates; Subcommittee and 

Work Group Reports; Board Working 

Time; and Conflict of Interest 

Requirements. 

The agenda is subject to change as 

priorities dictate. 

In the event an individual cannot 

attend, written comments may be 

submitted in accordance with the 

redaction policy provided below. Any 

written comments received will be 

provided at the meeting and should be 

submitted to the contact person below 

well in advance of the meeting. 

Policy on Redaction of Board Meeting 

Transcripts (Public Comment), (1) If a 

person making a comment gives his or 

her name, no attempt will be made to 

redact that name. (2) NIOSH will take 

reasonable steps to ensure that 

individuals making public comment are 

aware of the fact that their comments 

(including their name, if provided) will 

appear in a transcript of the meeting 

posted on a public Web site. Such 

reasonable steps include: (a) A 

statement read at the start of each public 

comment period stating that transcripts 

will be posted and names of speakers 

will not be redacted; (b) A printed copy 

of the statement mentioned in (a) above 

will be displayed on the table where 

individuals sign up to make public 

comment; (c) A statement such as 

outlined in (a) above will also appear 

with the agenda for a Board Meeting 

when it is posted on the NIOSH Web 

site; (d) A statement such as in (a) above 

will appear in the Federal Register 

Notice that announces Board and 

Subcommittee meetings. (3) If an 

individual, in making a statement, 

reveals personal information (e.g., 

medical information) about themselves, 

that information will not usually be 

redacted. The NIOSH FOIA coordinator 

will, however, review such revelations 

in accordance with the Freedom of 

Information Act and the Federal 

Advisory Committee Act and if deemed 

appropriate, will redact such 

information. (4) All disclosures of 

information concerning third parties 

will be redacted. (5) If it comes to the 

attention of the DFO that an individual 

wishes to share information with the 

Board but objects to doing so in a public 

forum, the DFO will work with that 

individual, in accordance with the 

Federal Advisory Committee Act, to 

find a way that the Board can hear such 

comments. 

Contact Person for More Information: 

Theodore Katz, M.P.A., Executive 

Secretary, NIOSH, CDC, 1600 Clifton 

Road, MS E–20, Atlanta, GA 30333, 

Telephone (513) 533–6800, Toll Free 

1(800) CDC–INFO, E-mail ocas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

Notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 


jlentini on DSKJ8SOYB1PROD with NOTICES
3912 Federal Register / Vol. 75, No. 15 / Monday, January 25, 2010 / Notices 

Dated: January 14, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–1274 Filed 1–22–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned committee: 

Times and Dates: 9 a.m.–5 p.m., February 

11, 2010. 9 a.m.–12 p.m., February 12, 2010. 

Place: CDC, Global Communications 

Center, Building 19, Auditorium B3, 1600 

Clifton Road, NE., Atlanta, Georgia 30333. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The Committee is charged with 

providing advice and guidance to the 

Secretary; the Assistant Secretary for Health; 

the Director, CDC; and the Director, National 

Center for Preparedness, Detection, and 

Control of Infectious Diseases (NCPDCID), 

regarding: (1) The practice of hospital 

infection control; (2) strategies for 

surveillance, prevention, and control of 

infections (e.g., nosocomial infections), 

antimicrobial resistance, and related events 

in settings where healthcare is provided; and 

(3) periodic updating of guidelines and other 

policy statements regarding prevention of 

healthcare-associated infections and 

healthcare-related conditions. 

Matters To Be Discussed: The agenda will 

include updates on CDC healthcareassociated infections Recovery Act efforts; 

discussion on the draft guideline for 

prevention of intravascular catheter-related 

bloodstream infections; and the draft 

guideline for the prevention and management 

of norovirus gastroenteritis outbreaks in 

healthcare settings. 

Agenda items are subject to change as 

priorities dictate. 

For Further Information Contact: Michelle 

W. King, Committee Management Specialist, 

Division of Healthcare Quality Promotion, 

NCPDCID, CDC, 1600 Clifton Road, NE., 

Mailstop A–07, Atlanta, Georgia 30333, 

Telephone (404) 639–2936. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 15, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC) . 

[FR Doc. 2010–1275 Filed 1–22–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Molecular 

Mechanisms of Neurodegeneration. 

Date: January 27, 2010. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1257, baizerl@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 15, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–1225 Filed 1–22–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID: FEMA–2009–0001] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request, 1660–0076; Hazard 

Mitigation Grant Program Application 

and Reporting 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice; 60-day notice and 

request for comments; revision of a 

currently approved information 

collection; OMB No. 1660–0076; No 

Form. 

SUMMARY: The Federal Emergency 

Management Agency, as part of its 

continuing effort to reduce paperwork 

and respondent burden, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on a proposed revision of a 

currently approved information 

collection. In accordance with the 

Paperwork Reduction Act of 1995, this 

Notice seeks comments concerning the 

Hazard Mitigation Grant Program 

application and reporting requirements. 

DATES: Comments must be submitted on 

or before March 26, 2010. 

ADDRESSES: To avoid duplicate 

submissions to the docket, please use 

only one of the following means to 

submit comments: 

(1) Online. Submit comments at 

http://www.regulations.gov under 

docket ID FEMA–2009–0001. Follow the 

instructions for submitting comments. 

(2) Mail. Submit written comments to 

Office of Chief Counsel, Regulation and 

Policy Team, DHS/FEMA, 500 C Street, 

SW., Room 835, Washington, DC 20472– 

3100. 

(3) Facsimile. Submit comments to 

(703) 483–2999. 

(4) E-mail. Submit comments to 

FEMA-POLICY@dhs.gov. Include docket 

ID FEMA–2009–0001 in the subject line. 

All submissions received must 

include the agency name and docket ID. 

Regardless of the method used for 

submitting comments or material, all 

submissions will be posted, without 

change, to the Federal eRulemaking 

Portal at http://www.regulations.gov, 

and will include any personal 

information you provide. Therefore, 

submitting this information makes it 

public. You may wish to read the 

Privacy Act notice that is available on 

the Privacy and Use Notice link on the 

Administration Navigation Bar of http:// 

www.regulations.gov. 


jlentini on DSKJ8SOYB1PROD with NOTICES